Telehealth Narcolepsy Prescribing: What Psychiatrists Can Do in Texas

If you’re a psychiatrist or PMHNP considering adding narcolepsy medication management to your telehealth practice, you’re probably wondering: Can I actually do this legally? What’s different from treating ADHD or depression? And what are the reimbursement and regulatory hoops I’ll need to jump through?

Here’s the reality: narcolepsy is a rare neurological sleep disorder affecting roughly 1 in 2,000 Americans—about 160,000 people nationwide—and most of them struggle to find providers who understand the condition and can prescribe the right medications. Sleep specialists are in short supply, especially in rural areas. That’s where psychiatrists and psychiatric nurse practitioners can step in, especially through telehealth.

But managing narcolepsy isn’t exactly like your typical med management for anxiety or ADHD. The medications are mostly controlled substances (Schedule II stimulants or Schedule IV wakefulness agents), the diagnosis usually requires sleep study confirmation, and the state-by-state prescribing rules can be a minefield—especially for nurse practitioners.

Let’s break down what you need to know to confidently (and legally) manage narcolepsy patients via telehealth, whether you’re an MD, DO, or PMHNP.

The Medications: What You’ll Actually Be Prescribing

Narcolepsy treatment centers on keeping patients awake during the day and, for those with cataplexy (sudden muscle weakness triggered by emotions), managing those episodes. The medication toolkit includes:

First-line stimulants (Schedule II):

• Methylphenidate (Ritalin, Concerta)
• Amphetamines (Adderall, Dexedrine)
• These are the same meds you prescribe for ADHD, but narcolepsy patients often need higher doses and different timing (morning dose plus midday booster).

Wakefulness-promoting agents (Schedule IV or non-controlled):

• Modafinil (Provigil) – Schedule IV
• Armodafinil (Nuvigil) – Schedule IV
• Solriamfetol (Sunosi) – Schedule IV
• Pitolisant (Wakix) – Non-scheduled

For cataplexy/disrupted nighttime sleep:

• Sodium oxybate (Xyrem, Xywav) – Schedule III, heavily regulated with a REMS program
• Sometimes SSRIs or SNRIs off-label

From a prescribing standpoint, you’re mostly dealing with controlled substances, which means DEA registration, PDMP checks, and navigating both federal and state telehealth rules for controlled substance prescribing.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Telehealth Rules: The Current Landscape (2025–2026)

Under normal circumstances (pre-COVID), the Ryan Haight Act required an in-person medical evaluation before prescribing any controlled substance. The pandemic changed that. The DEA suspended that requirement, allowing providers to prescribe Schedule II–V medications via telehealth without ever seeing the patient in person.

Good news for 2025–2026: That suspension has been extended through at least the end of 2025. As of November 2024, the DEA and HHS announced they’re continuing the telehealth flexibility for controlled substance prescribing, meaning psychiatrists and qualified PMHNPs can still initiate Adderall, modafinil, or other narcolepsy meds after a video evaluation alone—no in-person visit required.

What happens after 2025? Nobody knows for sure. The DEA has been working on permanent telemedicine prescribing rules, but they’re not finalized yet. For now, plan as if you can prescribe via telehealth through 2025, but stay alert for policy changes in 2026.

Practical compliance steps:

• Use audio-visual telehealth (video required, not just phone)
• Verify the patient’s identity and location
• Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing
• Use EPCS (electronic prescribing of controlled substances) – most states now mandate e-prescribing for Schedule II drugs
• Document the visit as thoroughly as you would in-person

Psychiatrists (MD/DO): What You Can Do via Telehealth

Short answer: Pretty much everything, in most states.

As a fully licensed physician, you have the broadest prescriptive authority. You can diagnose narcolepsy (ideally with a sleep study to back it up), prescribe any narcolepsy medication including Schedule II stimulants, and manage patients entirely via telehealth—provided you’re licensed in the patient’s state and follow that state’s telehealth rules.

State-specific wrinkles to watch for:

• Florida: Florida law prohibits prescribing Schedule II controlled substances via telehealth unless it’s for a psychiatric disorder, inpatient care, hospice, or chronic pain management. Technically, narcolepsy is a neurological disorder, not a psychiatric one. So if you’re treating a Florida patient purely for narcolepsy via telehealth, you might hit a legal wall with Schedule II stimulants. Workarounds: use modafinil (Schedule IV, which Florida allows via telehealth as of 2022), or require at least one in-person visit with a Florida physician before starting stimulants. If the patient also has ADHD or another psychiatric diagnosis, you might have more leeway.

• Texas, California, New York, Illinois, Pennsylvania: No physician-specific telehealth restrictions on prescribing narcolepsy meds. Follow federal allowances and state PDMP requirements, and you’re good.

Your workflow:

1. Initial evaluation (30–45 min video visit): Confirm diagnosis (review sleep study results—most narcolepsy diagnoses come from a sleep specialist after polysomnography and Multiple Sleep Latency Test). Take a full history, rule out other causes of excessive sleepiness (sleep apnea, depression, medication side effects). Assess for cataplexy or other symptoms.

2. Start medication: Typically begin with modafinil or a low-dose stimulant. Educate patient on timing (usually morning dose, sometimes midday booster), side effects (elevated BP, insomnia, appetite suppression), and safety (no driving until symptoms controlled).

3. Monthly follow-ups (15–20 min): Titrate dose, monitor side effects, review adherence, check blood pressure if on stimulants. Refill prescriptions (Schedule II requires a new script every 30 days—no refills). Document PDMP check each visit in many states.

4. Coordinate care: Stay in touch with the patient’s sleep specialist or PCP. You’re managing meds; they might handle sleep hygiene, CPAP if there’s comorbid apnea, or periodic sleep study updates.

Reimbursement: Bill E/M codes (99213 or 99214 for follow-ups, 99204/99205 for initial visits). Telehealth parity laws in most states ensure you’re paid the same as in-person visits. Medicare and most private insurers cover tele-psychiatry. Just be aware: narcolepsy uses a G47.4x ICD-10 code (neurological), not a psychiatric code—some insurers might route this through the medical benefit rather than behavioral health, but reimbursement should be similar.

The catch: You need to be licensed in every state where your patients are located. If you’re only licensed in California but want to treat patients nationwide, you’ll need to obtain licenses in each state (or use multi-state licensing compacts where available—though there’s no physician compact that covers prescribing yet).

PMHNPs: State-by-State Prescribing Authority for Narcolepsy

This is where it gets complicated. Nurse practitioners’ ability to prescribe narcolepsy medications depends heavily on their state’s scope-of-practice laws.

Full-Practice States (NPs Can Prescribe Independently After Meeting Requirements)

New York:

• After 3,600 hours of practice (about 2 years), PMHNPs can practice and prescribe independently—no physician oversight required.
• Can prescribe Schedule II–V controlled substances, including stimulants for narcolepsy.
• Must check the I-STOP PDMP before every controlled substance prescription.
• Telehealth: fully supported; no extra barriers.

Bottom line: Experienced NY PMHNPs can manage narcolepsy just like psychiatrists.

Illinois:

• Full Practice Authority (FPA) available after 4,000 hours of collaborative practice + 250 hours of continuing education.
• FPA-certified NPs can prescribe Schedule II–V independently.
• Special rules: If prescribing Schedule II opioids, you must maintain a physician consultation relationship (monthly discussions documented). If prescribing benzos for >120 days, physician consult required. Stimulants for narcolepsy have no such requirement.
• Telehealth: allowed; Illinois has strong parity laws.

Bottom line: Illinois PMHNPs with FPA can fully manage narcolepsy meds independently. Newer NPs need a collaborative agreement but can still prescribe under physician delegation.

California:

• AB 890 created a pathway to NP independence. As of 2023, NPs can practice as ‘103 NPs’ (in physician-supervised group settings, no individual oversight on each act). After 3+ years (4,600 hours) as a 103 NP, they can become ‘104 NPs’ (fully independent) starting in 2026.
• Until then, NPs need physician-approved standardized procedures to prescribe Schedule II drugs (including stimulants).
• By 2026, experienced CA PMHNPs can prescribe narcolepsy meds independently.

Bottom line: California is transitioning. If you’re an experienced PMHNP, you’ll have near-MD authority by 2026. Newer NPs need a collaborating physician’s protocol.

Restricted-Practice States (NPs Need Physician Oversight and Face Prescribing Limits)

Texas:

• All NPs must have a Prescriptive Authority Agreement (PAA) with a supervising physician.
• NPs cannot prescribe Schedule II drugs for outpatients except in hospital inpatient/ER settings or hospice care. This means you cannot prescribe Adderall or other Schedule II stimulants for narcolepsy in a typical clinic or telehealth practice.
• NPs can prescribe Schedule III–V (e.g., modafinil, armodafinil) with physician oversight, up to 90-day supply.

Bottom line: Texas PMHNPs cannot independently manage narcolepsy if stimulants are needed. You’d need your supervising physician to write those prescriptions, or use Schedule IV alternatives like modafinil. Telehealth is allowed, but the PAA and Schedule II restrictions make solo NP narcolepsy management nearly impossible.

Florida:

• PMHNPs must have a collaborative agreement with a physician. Florida’s autonomous NP law excludes psychiatric nurse practitioners.
• APRNs can prescribe Schedule II, but limited to a 7-day supply unless they’re certified ‘psychiatric nurses’ prescribing for psychiatric disorders.
• Narcolepsy isn’t a psychiatric disorder, so technically a Florida PMHNP could only prescribe 7 days of stimulants at a time—meaning weekly refills, which is impractical.
• Telehealth: Florida also restricts Schedule II prescribing via telehealth to psychiatric treatment, inpatient, or hospice. So a Florida tele-PMHNP treating narcolepsy faces double restrictions.

Bottom line: Florida PMHNPs face significant barriers to managing narcolepsy. Modafinil (Schedule IV) is an option, or rely on a collaborating psychiatrist for stimulant prescriptions. Florida’s rules make this one of the toughest states for NP narcolepsy management.

Pennsylvania:

• NPs (CRNPs) must have a written collaborative agreement with a physician.
• Can prescribe Schedule II for up to 30 days (and must notify the physician within 24 hours). Schedule III–IV up to 90 days.
• Telehealth: allowed; no specific state prohibition on controlled substances via telehealth.

Bottom line: PA PMHNPs can prescribe narcolepsy meds, but only under physician collaboration. Monthly 30-day limits on Schedule II align with typical stimulant management anyway, so this is workable—just requires physician partnership.

Quick Reference: PMHNP Narcolepsy Prescribing by State

If you’re a PMHNP: Know your state’s rules before taking on narcolepsy patients. In full-practice states, you’re golden. In restricted states, you’ll need a collaborating physician or plan to use Schedule IV alternatives.

The Narcolepsy-Specific Challenges (Beyond Just Prescribing Laws)

1. Diagnosis Confirmation

Unlike ADHD or depression, narcolepsy usually requires objective testing: a polysomnogram (overnight sleep study) followed by a Multiple Sleep Latency Test (daytime nap study). Most patients will come to you with a diagnosis from a sleep specialist.

If they don’t? You’ll need to refer them for testing before prescribing. Managing unconfirmed narcolepsy is risky—excessive daytime sleepiness could be sleep apnea, a medication side effect, depression, or a dozen other things. Sleep studies aren’t something you can order and interpret easily via telehealth; coordinate with local sleep centers.

2. Medication Shortages

The ongoing Adderall shortage (since mid-2022) has hit narcolepsy patients hard. Pharmacies often can’t fill prescriptions, forcing providers to switch patients to alternative stimulants or modafinil on short notice.

Your role: Be flexible. Have backup medications in mind (methylphenidate instead of amphetamine, or modafinil if the patient can tolerate it). Electronic prescribing helps you quickly send new scripts to different pharmacies. But this adds uncompensated work—patient calls, extra visits to adjust meds—so factor that into your practice model.

3. Prior Authorizations

Narcolepsy meds—especially modafinil, Sunosi, Wakix, and sodium oxybate—often require prior authorization. You’ll need to submit sleep study reports, chart notes, and sometimes proof that cheaper alternatives failed.

Reality check: This paperwork takes time (30–60 minutes per patient), and insurers don’t pay you for it. If you’re on a platform like Klarity that handles some admin burden, great. If not, build this into your workflow or charge patients a documentation fee.

4. Sodium Oxybate (Xyrem/Xywav) REMS Program

If you’re managing narcolepsy with cataplexy, patients might need sodium oxybate—a Schedule III controlled liquid taken at night. It’s only available through a single central pharmacy, and prescribers must enroll in a Risk Evaluation and Mitigation Strategy (REMS) program.

Is it worth it? Depends on your patient volume. For a few narcolepsy patients, probably not. Most tele-psychiatrists stick to stimulants and refer patients needing oxybate back to sleep specialists.

5. Higher Follow-Up Frequency

Narcolepsy medication management typically requires monthly visits during titration and at least every 3 months for stable patients. Schedule II prescriptions legally can’t be refilled (you write a new script each month), and patients often need dose adjustments.

This is more frequent than, say, stable depression or anxiety management (which might be every 3–6 months). But it also means steady, predictable patient volume and revenue.

Reimbursement: Can You Actually Get Paid for This?

Short answer: Yes, if you code correctly and understand parity laws.

For Psychiatrists:

• Bill E/M codes: 99214 for a typical 20-minute follow-up (moderate complexity—adjusting doses, managing side effects). 99213 if it’s straightforward and brief. Initial visits: 99204 or 99205.
• Medicare allowable for 99214: roughly $110–$130 (varies by locality). Private insurance: $140–$160 before negotiation.
• Annual revenue per patient: If you see a narcolepsy patient monthly, that’s 12 visits/year at ~$100–$130 each = $1,200–$1,560/patient/year in reimbursement (before overhead).

For PMHNPs:

• Same E/M codes. Medicare pays NPs at 85% of the physician fee schedule (so ~$93–$110 per 99214 instead of $110–$130).
• Private insurers often pay NPs the same as MDs if in-network, but overall mental health reimbursement averages 22% lower than other specialties—a known parity issue.

Telehealth Parity Laws:

Most states now require insurers to reimburse telehealth visits at the same rate as in-person:

• New York, California, Illinois: Strong parity laws. Tele-psychiatry paid equally.
• Texas, Florida, Pennsylvania: Also have parity provisions for telehealth mental health services.

The catch: Some insurers still underpay or delay mental health claims. Many psychiatrists go out-of-network or cash-pay to avoid hassles. For narcolepsy, you might offer patients a self-pay option (e.g., $150–$200/visit) if insurance is difficult. Given the scarcity of providers, many patients will pay out-of-pocket.

Cash-Pay Economics:

If you charge $150 per follow-up and see a patient monthly for 6 months, then quarterly: that’s ~9 visits/year = $1,350/patient/year in revenue with zero insurance headaches. Multiply by 20 narcolepsy patients = $27,000/year in predictable income just from this patient segment.

Efficiency matters: Telehealth lets you see more patients per day (no commute for you or them, lower no-show rates). A focused 15-minute med check via video is billable and profitable. Platforms like Klarity handle scheduling, reminders, and billing, so you maximize clinical time.

Why Join a Platform Like Klarity for Narcolepsy Management?

Here’s the business case:

Patient acquisition: Finding narcolepsy patients on your own is tough. SEO takes 6–12 months. Google Ads for ‘narcolepsy treatment’ cost $15–$40/click, and most clicks don’t convert. Psychology Today listings? You’re competing with hundreds of other providers on the same page.

Klarity’s model: We bring pre-qualified patients to you. You only pay per appointment (similar to Zocdoc)—no upfront marketing spend, no monthly subscription fees. Patients are already matched to your specialty and availability, so you’re not wasting time on no-shows or unqualified leads.

Math: Instead of spending $3,000–$5,000/month on marketing with uncertain ROI, you pay only when a patient books. For narcolepsy—a niche but high-need population—this is guaranteed patient flow without the risk.

Built-in infrastructure:

• EPCS-enabled e-prescribing (required for controlled substances)
• PDMP integration (or guidance on state-specific checks)
• Automated appointment reminders (reduces no-shows)
• Insurance billing support or seamless cash-pay processing
• Both insurance-accepting and self-pay patient options

Control your schedule: You decide your hours and patient load. Only see patients when you’re available. No overhead of running your own practice, no staff to manage.

For PMHNPs in restricted states: Klarity can help facilitate collaborative agreements with supervising physicians in Texas, Florida, or Pennsylvania. We understand the compliance complexities and match you with physician partners where needed.

Frequently Asked Questions

Q: Can I prescribe Adderall for narcolepsy via telehealth in 2026?

A: As of early 2026, yes—under the extended DEA telehealth allowance through at least the end of 2025. However, state laws matter: Texas NPs cannot prescribe Schedule II outpatient, and Florida has telehealth restrictions on Schedule II for non-psychiatric conditions. Psychiatrists (MDs) have broader authority but must still follow state telehealth rules. Expect possible changes after 2025 when DEA finalizes new telemedicine prescribing regulations.

Q: What’s the difference between treating narcolepsy and treating ADHD as a prescriber?

A: Clinically, narcolepsy often requires higher stimulant doses, different timing (morning + midday), and coordination with sleep specialists (for diagnosis confirmation and managing comorbid sleep disorders). Legally, it’s similar—both involve Schedule II stimulants. But narcolepsy is coded as a neurological disorder (G47.4x), which might route insurance differently. Also, narcolepsy patients often need additional meds for cataplexy (like sodium oxybate), which ADHD patients don’t.

Q: Do I need a sleep medicine board certification to treat narcolepsy?

A: No. Psychiatrists and PMHNPs can manage narcolepsy medications within their scope of practice. However, confirming the diagnosis typically requires sleep studies interpreted by sleep medicine specialists. You’ll usually work with a neurologist or sleep specialist who diagnosed the patient, and you handle the ongoing medication management. Think of it as collaborative care.

Q: How do I handle PDMP checks for monthly stimulant prescriptions?

A: Most states require checking the Prescription Drug Monitoring Program before prescribing controlled substances. Some (like New York) require it every time. Others (like Illinois) require it at initiation and periodically. Check your state’s rules. Best practice: check the PDMP at every visit for narcolepsy patients on Schedule II drugs. Document that you checked it in your note. Modern EHRs and platforms like Klarity often integrate PDMP access or provide guidance on compliance.

Q: What if my narcolepsy patient can’t get their Adderall filled due to shortages?

A: Have backup options ready. Switch to methylphenidate (Ritalin) if amphetamine is unavailable, or try modafinil/armodafinil (different mechanism, Schedule IV, often easier to find). Communicate with the patient quickly—call or message them with alternative prescriptions. Electronic prescribing lets you send new scripts to different pharmacies in minutes. This is extra work, but it’s part of managing controlled substances in the current shortage environment.

Q: Can PMHNPs in Texas manage narcolepsy patients at all?

A: Only partially. Texas PMHNPs can prescribe Schedule IV wakefulness agents (modafinil, armodafinil) under their Prescriptive Authority Agreement with a physician. They cannot prescribe Schedule II stimulants (Adderall, Ritalin) for outpatients—only the collaborating physician can do that. So in practice, a Texas PMHNP could manage a narcolepsy patient on modafinil, but if the patient needs amphetamines, the supervising MD would have to write those prescriptions. This limits independent NP narcolepsy management in Texas.

Q: Is narcolepsy medication management via telehealth reimbursed the same as in-person?

A: In most states, yes—thanks to telehealth parity laws. Medicare and many private insurers reimburse tele-psychiatry at the same rate as in-person visits (with some exceptions: Medicare pays NPs at 85% of the physician rate). However, overall mental health provider reimbursement is often lower than other specialties (~22% less on average from private insurers). Some psychiatrists opt out of insurance and go cash-pay for this reason. Narcolepsy, being coded as a neurological condition, might sometimes get routed through medical benefits rather than behavioral health, but reimbursement should be comparable. Always verify with individual payers.

Final Takeaway: Should You Add Narcolepsy to Your Telehealth Practice?

If you’re a psychiatrist (MD/DO): Absolutely consider it. You have full prescriptive authority in every state (with minor telehealth exceptions like Florida). Narcolepsy is underserved—160,000 Americans need care, and most can’t find providers. You already know how to prescribe and monitor stimulants from ADHD management. The workflow is efficient (short, focused visits), reimbursement is solid (especially via telehealth parity), and patient demand is high. Partner with a platform like Klarity to avoid the marketing headache and get pre-qualified patient flow.

If you’re a PMHNP: It depends on your state. In New York, Illinois, or California (after 2026), you can manage narcolepsy nearly as independently as a psychiatrist—great opportunity, especially in underserved areas. In Texas or Florida, you’ll need a collaborative physician or plan to use Schedule IV alternatives (modafinil) since stimulant prescribing is restricted. Pennsylvania is workable with physician partnership. Know your state’s rules, ensure you have the right agreements in place, and you can carve out a niche in narcolepsy care.

Economics: Whether you’re billing insurance or offering cash-pay, narcolepsy medication management provides steady, recurring revenue (monthly or quarterly visits). The patient population is loyal (chronic condition, ongoing need), and with the right platform support, you can practice efficiently without drowning in prior authorizations or PDMP compliance headaches.

The bottom line: Narcolepsy is a clinical niche with real demand, manageable complexity (if you’re comfortable with stimulants and controlled substance regulations), and solid reimbursement. Telehealth makes it accessible—for both you and patients who desperately need providers who understand their condition.

If you’re ready to expand your practice and help an underserved patient population, narcolepsy medication management via telehealth is worth serious consideration. Platforms like Klarity remove the patient acquisition risk, handle the tech and compliance infrastructure, and let you focus on what you do best: providing expert medication management and improving patients’ quality of life.

Sources & References

1. Axios – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024)
   https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
   Confirms DEA/HHS extension of telehealth controlled-substance allowances through end of 2025.

2. Texas Medical Board – FAQ on Schedule II delegation
   https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation
   Official guidance: Texas NPs/PAs can only prescribe Schedule II in hospital inpatient or hospice settings.

3. California Board of Registered Nursing – AB 890 implementation page
   https://www.rn.ca.gov/practice/ab890.shtml
   Details California’s NP independence pathway (103/104 NP categories, 2026 timeline).

4. Florida Statutes – Section 464.012 (Nurse Practice Act)
   https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All
   Primary law text: 7-day Schedule II limit for APRNs, exception for psychiatric nurses.

5. Rivkin Radler – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (Apr 13, 2022)
   https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/
   Summarizes NY’s permanent NP independence after 3,600 hours (2023 budget law).

6. 49 Pa. Code §21.284 – PA Nursing Code (prescribing limitations)
   https://www.pacodeandbulletin.gov/Display/pacode?file=/secure/pacode/data/049/chapter21/s21.284.html
   Official Pennsylvania regulations: 30-day Schedule II limit, 90-day Schedule III–IV limit for NPs.

7. Illinois Nurse Practice Act – Full Practice Authority section (225 ILCS 65/65-43)
   https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act
   Primary statute: Illinois FPA requirements (4,000 hours + 250 CE hours) and consultation rules for opioids/benzos.

8. MedicalXpress (KFF Health News) – ‘Narcolepsy patients face med shortages & stigma’ (Jan 3, 2024)
   https://medicalxpress.com/news/2024-01-patients-narcolepsy-dual-nightmare-medication.html
   Reports narcolepsy prevalence (1 in 2,000) and ongoing Adderall shortage impact.

9. Axios – ‘Texas churches step in amid mental health access crisis’ (Aug 7, 2024)
   https://www.axios.com/local/san-antonio/2024/08/07/texas-churches-religion-mental-health-response
   Cites Mental Health America data: Texas ranks last in mental health access, workforce availability.

10. Axios – ‘Illinois bill could make mental health care more affordable’ (Mar 6, 2025)
    https://www.axios.com/local/chicago/2025/03/06/illinois-mental-health-bill-reimbursement-rates
    Reports private insurers pay mental health providers 22% less than other physicians; Illinois legislative efforts to address parity.

11. Clinical Advisor – ‘Is Medicare’s 85% reimbursement rule fair?’ (Feb 10, 2012)
    https://www.clinicaladvisor.com/home/the-waiting-room/is-medicares-85-reimbursement-rule-fair/
    Confirms Medicare reimburses NPs/PAs at 85% of physician fee schedule.

12. National Law Review – ‘Florida telehealth prescribing law (SB 312)’ (Apr 7, 2022)
    https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances
    Legal analysis: Florida SB 312 allows Schedule III–V via telehealth but maintains Schedule II restrictions (psychiatric, inpatient, hospice exceptions).

13. NYS Education Department – NP Practice FAQ
    https://www.op.nysed.gov/professions/nurse-practitioners/practice-issues/collaborative-practice-with-physicians
    Official guidance on NY collaborative agreements and practice protocols for nurse practitioners.

14. Axios – ‘Biden admin addresses mental health parity, workforce shortages’ (Aug 1, 2023)
    https://www.axios.com/2023/08/01/biden-mental-health-parity-behavioral-workforce-shortages

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority